Drug intelligence / Profile preview

JenaCid

Development stage: Unknown
Lead developer: Jena Herbals
Administration: Oral

Overview

JenaCid is a botanical medicinal product developed and manufactured by Jena Herbals Limited in Uganda. It is formulated from a proprietary blend of indigenous herbal extracts intended to alleviate symptoms of hyperacidity, peptic ulcers, and gastroesophageal reflux (heartburn). The product was developed under the direction of Prof. Patrick Ogwang and is registered with the Uganda National Drug Authority (NDA) as a finished herbal medicine. It is marketed as a natural alternative to synthetic antacids, aiming to neutralize stomach acid and provide a protective layer to the gastric mucosa.

Brand names: JenaCid
Other names: Jena Cid

Beyond the preview

Go deeper on JenaCid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JenaCid.

Explore the full profile